Career history of Konrad Glund
Former positions of Konrad Glund
| Companies | Position | Start | End |
|---|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Chief Executive Officer | 2005-12-31 | 2018-04-29 |
| Founder | 1997-07-24 | 2018-04-29 | |
Prosidion Ltd.
 Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Corporate Officer/Principal | 2004-07-31 | - |
| Martin-Luther-Universität Halle-Wittenberg | Corporate Officer/Principal | - | - |
| IFB Halle GmbH | Chief Executive Officer | - | - |
| Founder | - | - |
Training of Konrad Glund
| Martin-Luther-Universität Halle-Wittenberg | Doctorate Degree |
Statistics
International
| Germany | 4 |
| United Kingdom | 2 |
Operational
| Chief Executive Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Private companies | 2 |
|---|---|
Prosidion Ltd.
Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Health Technology |
| IFB Halle GmbH |
- Stock Market
- Insiders
- Konrad Glund
- Experience
